If you notice changes in memory, thinking, or behavior in yourself, someone you know, or someone you care for, these resources can help. The Brain Health Journey is a set of useful resources to help you understand what may be happening and what steps you can take next.
Navigating Changes in Brain Health
This interactive tool offers detailed information on key stages of the care journey for someone experiencing changes in memory and thinking, as well as family members and care partners. You’ll find answers to common questions and links to trusted resources to support you along the way.
Informed by Expertise and Lived Experience
These resources were made with direct input from people with lived experience and professional expertise. UsAgainstAlzheimer's convened two advisory groups that provided ongoing feedback through group discussions, one-on-one conversations, and document review.
A human-centered design firm led design efforts and regularly obtained feedback at every stage from both advisory groups. This process enhanced and refined tools to further ensure that the tools are practical, respectful, and responsive to real-world needs. Learn more about the committee members below.
- Lived experience advisory group: People living with mild cognitive impairment due to Alzheimer’s disease, people living with increased risk of Alzheimer’s disease (APOE e4 carriers), current and former caregivers to family members with Alzheimer’s disease, licensed clinical social workers, etc.
- Expert advisory group: dementia experts, general neurologists, primary care providers, specialists, researchers, licensed clinical social workers, and nurses.
UsAgainstAlzheimer’s is a nonprofit patient advocacy organization working to catalyze change in the health ecosystem to improve dementia prevention, early detection, and access to treatments. It conducts advocacy, policy, convening, and high-leverage programs, with a particular focus on health equity. This project was made possible thanks to funding from sponsors Novo Nordisk, Bristol Myers Squibb, Eli Lilly, and Genentech.
